Amerifit Brands on Wednesday launched its Azo PMS product, which has been formulated to help reduce moodiness, irritability and bloating with a variety of ingredients, including high-potency B vitamins, calcium, magnesium, folic acid and two natural herbal blends, the company stated.
Researchers from the University of Texas Health Science Center at Houston found that patients with diabetes are at higher risk of contracting tuberculosis, a deadly bacterial disease, than nondiabetics.
Alterna, a marketer of personal care products and therapeutic over-the-counter medicines, has signed a new trademark and know-how license agreement with Spirig Pharma AG of Egerkingen, Switzerland, which expands Alterna's exclusive rights to distribute Kerasal one-step exfoliating moisturizing foot ointment to 80 countries outside of North America.
The National Association of Chain Drug Stores announced that it submitted on Tuesday a statement to the Senate Subcommittee on Crime and Terrorism for the "Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud" hearing.
CVS Caremark outlined on Tuesday at a consumer health engagement conference the results of a personalized consumer communications program designed to encourage patients to take their medications as doctors direct.
Women that experience body mass index gains between their first and second pregnancies are at an increased risk of developing gestational diabetes in the second pregnancy, according to a Kaiser Permanente study.
Reps. Aaron Schock, R-Ill., and Peter Welch, D-Vt., on Monday introduced legislation that would exempt community pharmacies with less than 10 locations from having to participate in Medicare competitive acquisition programs and pricing when it comes to the sale of blood-glucose meters and supplies.
A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.
More and more, there is a new niche being carved out of the take-home test kits being offered through pharmacy. It used to be only pregnancy and ovulation test kits that were available in that space. Now there is a plethora of offerings, including tests for drug abuse, screenings for such conditions as high cholesterol, paternity tests and tests for sexually transmitted diseases.
Church & Dwight in April launched the First Response Digital Ovulation Test, a new at-home ovulation test that can detect a woman’s personal luteinizing hormone surge — the hormonal indication of ovulation — based on her own individual hormone levels.
It’s not often a niche brand manufacturer attempts to resuscitate what has been for years a commoditized category. But that’s exactly what Meda Consumer Healthcare will be attempting to do with iron — establish a good/better/best proposition to a supplemented category best defined as mediocre.